| September 13, 2025, Saturday | ||
|---|---|---|
| Hall A | Hall B | |
| 13:20-14:35 | Scientific Session 7a Oral Presentation - Clinical |
Scientific Session 7b Oral Presentation - Laboratory/MSK/Multi-disciplinary |
| 13:20-13:32 |
Emicizumab Prophylaxis in Children with Haemophilia A: Experience in Northern Peninsular Malaysia
Presenter: Ming Ang
Penang General Hospital, Pulau Pinang
|
Integrating Clinical, Laboratory, and Genomic Insights in Hemophilia C: A 25-Year Experience from North India
Presenter: Narender Kumar
Post Graduate Institute of Medical Education & Research, Chandigarh
|
| 13:32-13:44 |
Efanesoctocog alfa: better protection, longer half-life and??shorter activated partial thromboplastin time(aPTT), a single Institute experience
Presenter: Wan-Yi Hsu
Kaohsiung medical university hospital, Kaohsiung
|
Multidimensional Phenotyping of Discrepant Hemophilia A: Bridging Diagnostic Discordance Using Functional and Global Hemostasis Assays
Presenter: Anusha Thangaraja
Christian Medical College, Vellore
|
| 13:44-13:56 |
Lower Dose Emicizumab in Pediatric Hemophilia A: Clinical Outcomes and the Utility of Global Hemostasis Assays
Presenter: Neeraj Sidharthan
Amrita Institute of Medical Sciences, Kerala
|
Compliance With Treatment Diary Recording Among Hemophilia Patients and Caregivers at the National Institute of Hematology and Blood Transfusion, Vietnam
Presenter: Thi Hien Pham
National Institute of Hematology and Blood Transfusion, Hà Nội
|
| 13:56-14:08 |
The three patients who developed factor VIII inhibitor during efanesoctocog alpha prophylaxis in Japan
Presenter: Satoshi Higasa
Hyogo Medical University Hospital, Nishinomiya
|
A report of self-infusion workshop among patients and caregivers from the Hemophilia Treatment Center in Jakarta, Indonesia
Presenter: Dita Yusnita
Dr. Cipto Mangunkusumo Hospital, Jakarta
|
| 14:08-14:20 |
Real-world Experience of Clinical Outcomes of Pre- and Post- Switching to Efanesoctocog alfa Prophylaxis for People with Severe Hemophilia A: A Preliminary Study in Taiwan
Presenter: Chia-Yau Chang
Taipei Medical University Hospital, Taipei
|
An enhanced Functional Independence Score for Haemophilia (e-FISH) for early detection of musculoskeletal changes
Presenter: Priya Srikumar
Christian Medical College, Vellore
|
| 14:20-14:32 |
Intracranial hemorrhage in pediatric hemophilia: clinical characteristics, management, and outcomes
Presenter: Tuan Nguyen
Children's Hospital, Ho Chi Minh
|
Joint Health Trajectories in Severe Hemophilia: A Decade of Pettersson Data from Taiwan
Presenter: Te-Fu Weng
Chung Shan Medical University Hospital, Taichung
|
| Abstracts Selected for Oral Presentations | |||||
| Session Date: September 07, 2024 | |||||
| Session Timings: 13:35 - 14:35 hrs (IST) | |||||
| Hall | Abstract Category | Abstract ID | Abstract Title | Presenting Author | Presenting Author Affiliation |
| Hall A | Medical | 76 | Efficacy of Low Dose Emicizumab Prophylaxis in Hemophilia A: Real World Experience | Veronica Lobo | St. Johns Medical College Hospital, Bangalore |
| 70 | Real-world Clinical Care Regimens And their Associated Costs for Patients with Severe Hemophilia A and B in Eight Hemophilia Treatment Centers in Six Asian Low- and Middle-Income Countries | Nita Radhakrishnan | Post Graduate Institute of Child Health, Noida | ||
| 57 | Efficacy and safety of Mim8 prophylaxis in adults and adolescents with hemophilia A with or without inhibitors: Phase 3, open label, randomized, controlled FRONTIER2 study | Chandrakala Shanmukhaiah | Seth GS Medical College and KEM Hospital, Mumbai | ||
| 005 | Interim results of multi-country survey to evaluate disease burden, patient journey, and unmet needs in people with haemophilia A and haemophilia B (with and without inhibitors). | Darintr Sosothikul | King Chulalongkorn Memorial Hospital, Bangkok | ||
| 006 | A Non-Interventional Study to Evaluate Impact of Emicizumab in the Treatment of Bleeding Episodes, on Joint Health and Quality of Life in Participants with Hemophilia A | Anupam Dutta | Assam Medical College and Hospital, Dibrugarh | ||
| 69 | Impact of Prophylaxis Treatment in Children with Severe Hemophilia A Over a Decade – A Retrospective Single Center Study | Lincy Paul | Amrita Institute of Medical Sciences, Kochi | ||
| Hall B | Musculoskeletal | 12 | Non-Surgical correction of knee flexion deformity in persons with haemophilia – A staged multidisciplinary approach | Merlyn Tilak | Christian Medical College, Vellore |
| 87 | Evaluation of joint health of hemophilia patients using Haemophilia Joint Health Score (HJHS) at Ulin General Hospital Banjarmasin, Indonesia | Wulandewi Marhaeni | Universitas Lambung Mangkurat, Banjarmasin | ||
| Comprehensive Care: Nursing, Physiotherapy, Dental, Psychosocial |
22 | Clinical and Financial Outcomes of Surgical Care in Haemophilia Patients at a North India HTC Centre: A Retrospective Study | Diksha sarwan | Christian Medical College, Ludhiana | |
| 82 | Innovative use of LASER therapy in a Hemophilia A patient with aggressive periodontitis: A Case study | Sushmitha Dandamudi | Little Stars & She Hospital for Children and Women, Hyderabad | ||
| Laboratory | 52 | Insights into the clinical profiles and molecular genetics of Hemophilia A in North Indian Patients. | Ritika Sharma | PGIMER, Chandigarh | |
| 13 | The genotype-inhibitor phenotype association among north Indian patients with severe Hemophilia A | Narender Kumar | PGIMER, Chandigarh | ||
